SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sebi imposes fine of Rs 14 lakh on Biocon, its designated person for violation of market norms

21 May 2021 Evaluate

Markets regulator Sebi has imposed a total fine of Rs 14 lakh on Biocon and its designated person for violation of market norms. Designated person of the firm, Narendra Chirmule, who was employed with the company as senior vice president-R&D is facing a fine of Rs 5 lakh for trading in the company's securities when the trading window was closed.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

419.45 1.25 (0.30%)
02-Jul-2026 11:58 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1877.00
Dr. Reddys Labs. 1349.60
Cipla 1461.60
Zydus Lifesciences 1099.75
Lupin 2391.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: